AI Predicts Cardiovascular Disease Risk Beyond Genetics | MobiHealthNews
A new predictive model developed in Hong Kong is enabling more dynamic monitoring of six common cardiovascular diseases by capturing near-real-time biological changes, moving beyond a reliance on genetic predispositions for risk assessment. The model, unveiled March 23, 2026, utilizes considerable data analytics to track subtle shifts in biological markers, offering a potentially more responsive approach to cardiovascular health management.
The development arrives as artificial intelligence continues to reshape the landscape of non-communicable disease (NCD) detection and management globally. According to a report published in 2025, NCDs – including heart attacks, strokes, diabetes, cancers and chronic respiratory diseases – account for over 70% of all deaths worldwide. Traditional healthcare systems have struggled with early detection and long-term management of these complex conditions, but AI is increasingly being deployed to address these challenges.
The Hong Kong model’s focus on dynamic monitoring represents a shift from the traditional emphasis on genetic factors. While genetics play a role in cardiovascular risk, lifestyle, environmental factors, and access to care are too critical determinants. AI’s ability to analyze vast datasets allows for the integration of these diverse factors, providing a more holistic risk profile. A study published in PubMed highlights AI’s potential to address manpower shortages and accessibility issues in the management of chronic diseases, particularly in low- and middle-income countries.
The increasing role of AI in healthcare is attracting significant investment. Verily Health recently secured $300 million, with Alphabet becoming a minority investor, to accelerate the development of its AI precision health platform. Latent also recently raised $80 million to enhance its platform automating medication approval workflows. These investments signal a growing confidence in AI’s ability to transform healthcare delivery.
Beyond risk prediction, AI is also being utilized in other areas of NCD management. AI-driven tools, such as Cherish’s ambient monitoring device, are enabling in-home care for aging patients and those with cognitive decline, reducing the need for wearables or constant app interaction. The Centers for Medicare & Medicaid Services (CMS) is also adopting an AI-enhanced fraud detection approach, offering suspected providers education and opportunities to correct billing errors.
The 2026 HIMSS Global Health Conference & Exhibition featured extensive discussion of AI applications in healthcare, with attendees highlighting the technology’s potential and offering practical advice for implementation. The AI in Healthcare Forum, scheduled for two days of immersive sessions, will further explore the real-world application of AI in health and care.
Despite the growing optimism, experts caution that AI must be used responsibly and rationally. The potential for bias in algorithms and the need for robust data privacy protections remain key concerns. The long-term impact of AI on the healthcare workforce also requires careful consideration.